Vitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studies

Proceedings of the Nutrition Society

Volumn 72, Issue 1, 2013, Pages 89-97

  Khan, Hassan ^a   Kunutsor, Setor ^a   Franco, Oscar H ^b   Chowdhury, Rajiv ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Insulin resistance; Metabolic syndrome; Prospective epidemiological studies; Type 2 diabetes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

CONFERENCE PAPER; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INCIDENCE; INSULIN RESISTANCE; LATITUDE; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; REFERENCE DATABASE; SEASONAL VARIATION; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL;

DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; NUTRITIONAL STATUS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872865426     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665112002765     Document Type: Conference Paper

References (44)

1. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clinl Nutr 80, 6 Suppl., 1689S-1696S.
2. 3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134, 1602-1610.
3. Hypponen E, Laara E, Reunanen A et al. (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358, 1500-1503. (Pubitemid 33055701)
4. Rostand SG (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150-156. (Pubitemid 27328990)
5. Pittas AG, Chung M, Trikalinos T et al. (2010) Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152, 307-314.
6. Pittas AG, Sun Q, Manson JE et al. (2010) Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33, 2021-2023.
7. Scragg R, Sowers M, Bell C, Third National H, Nutrition Examination S (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813-2818. (Pubitemid 39565042)
8. Liu E, Meigs JB, Pittas AG et al. (2010) Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham offspring study. Am J Clin Nutr 91, 1627-1633.
9. Mitri J, Muraru MD & Pittas AG (2011) Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65, 1005-1015.
10. Stroup DF, Berlin JA, Morton SC et al. (2000) Meta-analysis of observational studies in epidemiology. JAMA: J Am Med Assoc 283, 2008-2012.
11. Danesh J, Collins R, Appleby P et al. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA: J Am Med Assoc 279, 1477-1482. (Pubitemid 28228207)
12. DerSimonian R & Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177-188. (Pubitemid 17189972)
13. Higgins JP, Thompson SG, Deeks JJ et al. (2003) Measuring inconsistency in meta-analyses. Br Med J 327, 557-560. (Pubitemid 37088507)
14. Higgins JP & Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558. (Pubitemid 34746062)
15. Begg CB & Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101.
16. Egger M, Davey Smith G, Schneider M et al. (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315, 629-634. (Pubitemid 27387172)
17. Gagnon C, Lu ZX, Magliano DJ et al. (2012) Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study: AusDiab). J Clin Endocrinol Metab 97, 1953-1961.
18. Knekt P, Laaksonen M, Mattila C et al. (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19, 666-671.
19. Kirii K, Mizoue T, Iso H et al. (2009) Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52, 2542-2550.
20. Thorand B, Zierer A et al. (2011) Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation. Diabetes Care 34, 2320-2322.
21. Kayaniyil S, Retnakaran R, Harris SB et al. (2011) Prospective associations of vitamin D with b-cell function and glycemia. Diabetes 60, 2947-2953.
22. Deleskog A, Hilding A, Brismar K et al. (2012). Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 55, 1668-1678.
23. Grimnes G, Emaus N, Joakimsen RM et al. (2010) Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 27, 1107-1115.
24. Robinson JG, Manson JE, Larson J et al. (2011) Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 34, 628-634.
25. Liu S, Song Y, Ford ES et al. (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women.Diabetes Care 28, 2926-2932. (Pubitemid 43942926)
26. Pittas AG, Dawson-Hughes B, Li T et al. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650-656. (Pubitemid 44115368)
27. Husemoen LL, Thuesen BH, Fenger M et al. (2012) Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study. Diabetes Care 35, 1695-1700.
28. Gagnon C, Lu ZX, Magliano DJ et al. (2011) Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years. Diabetes Care 34, 1133-1138.
29. Forouhi NG, Luan Ja, Cooper A et al. (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance. Diabetes 57, 2619-2625.
30. Fung GJ, Steffen LM, Zhou X et al. (2012) Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: the coronary artery risk development in young adults study. Am J Clin Nutr 96, 24-29.
31. Kayaniyil S, Retnakaran R, Harris SB et al. (2011) Prospective associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 60, 2947-2953.
32. Forouhi NG, Luan J, Cooper A et al. (2008) Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the medical research council ely prospective study 1990-2000. Diabetes 57, 2619-2625.
33. Labriji-Mestaghanmi H, Billaudel B, Garnier PE et al. (1988) Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. J Endocrinol Invest 11, 577-584.
34. Chiu KC, Chu A, Go VL et al. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820-825. (Pubitemid 41103882)
35. Boucher BJ, Mannan N, Noonan K et al. (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 1239-1245.
36. Gedik O & Akalin S (1986) Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29, 142-145. (Pubitemid 16137021)
37. Chertow BS, Sivitz WI, Baranetsky NG et al. (1983) Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113, 1511-1518. (Pubitemid 13009167)
38. Maestro B, Davila N, Carranza MC et al. (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84, 223-230. (Pubitemid 36514839)
39. Maestro B, Campion J, Davila N et al. (2000) Stimulation by 1 25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383-391.
40. Parker J, Hashmi O, Dutton D et al. (2010) Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65, 225-236.
41. Pittas AG, Lau J, Hu FB et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029. (Pubitemid 46997093)
42. Renzaho AMN, Halliday JA and Nowson C (2011) Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition 27, 868-879.
43. Willett W (1998) Nutritional Epidemiology, 2nd ed. New York: Oxford University Press.
44. Collaboration ERF (2007) The emerging risk factors collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 22, 839-869.